Supplier Type
- Manufacturer
- Reagent
- Trader
- custom synthesis
- contract manufacturer
Supplier Region
- Hyderabad(24)
- Maharashtra(36)
- Bangalore(3)
- Pune(8)
- Mumbai(68)
- Gujarat(42)
- New Delhi(8)
- Ahmedabad(16)
- Karnataka(6)
- Beijing(2)
- Andhra Pradesh(2)
- Uttar Pradesh(5)
- Telangana(4)
- Punjab(2)
- Haryana(3)
- Madhya Pradesh(1)
- Vadodara(12)
- Kolkata(3)
- Delhi(12)
- Tamil Nadu(2)
- Nagpur(1)
Purity
- Zirconium Octoate 6%, 12%, 18%, 24%
- Salicylic Acid
- Rasagiline Mesylate Impurity C
- NLT 95%
- NLT 90%
- more than 95%
- more than 90%
- Min 98%
- Mesalazine EP Impurity H
- Mathadone (M225865) impurity. Used in synthesis of methadone, antispasmodics and other pharmaceutica
- Greater than 99%
- Dipropargyl r- amino indane
- Dapagliflozin Intermediate, Dapagliflozin Impurity
- Content of Chromium 0.2 % to 0.3 %
- API Impurity / In-house working standard
- Acetylsalicylic Acid EP Impurity C
- ABOVE 99%
- 99.98%
- 99.95%
- >99.95%
- 99.91%
- 99.90%
- 99.9%
- 99.86%
- 99.85%
- 99.80%
- 99.73%
- 99.55%
- 99.5%
- 99.42%
- 99.29%
- 99.00%
- >99%
- 99%
- 98.90%
- 98.60%
- 98.58%
- 98.57%
- 98.12%
- 98.00%
- > 98%
- >98%
- 98%
- 97-99%
- 97.85%
- 97.80%
- 97.57%
- 97.00%
- 97%
- >97%
- 97 %
- 96-98%
- 96.80%
- 96.64%
- 96.40%
- 96.39%
- 96%
- 95.00%
- >95%
- 95%
- 94.00%
- >92%
- 90%
- >90%
- 90 % Above
- 3-8%, 12%
- 25 MG 50 MG 100 MG 250 MG EXTRA
- 12%/15%
- 12%
- 10-12 %
- 100%
- 100
- 0.5M
- (R)-N,N-di(prop-2-yn-1-yl)-2,3- dihydro-1
Package
- 2.5501e+00925 MG 50 MG 100 MG 250 MG EXTRA
- 0MG TO GRAM
- 1g
- 5g
- 10g
- 25g
- 50g
- 100ml
- 100g
- 500ml
- 500g
- 1L
- 50kg
- 100kg
- 500kg
- 11Between 1 gm to 1 MT (As per availability)
- 1mg
- 25mg
- 50mg
- 100mg
- 250mg
- 500mg
- 1gm
- 1kg
- 5kg
- 10kg
- 25kg
- 250kg
- 1MT
- 1and gm
- 95NLT %
- 250250 mg.
-
1-((2S,3R,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)-3-methyltetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione
2041584-99-8
-
6-Chloro-2-(chloroMethyl)-4-(2-fluorophenyl)-1,2-dihydroquinazoline 3-Oxide
60656-72-6
-
N-((S)-1-(3-(3-amino-4-chloro-1-(2,2,2-trifluoroethyl)-1H-indazol-7-yl)-6-(3-methyl-3-(methylsulfonyl)but-1-yn-1-yl)pyridin-2-yl)-2-(3,5-difluorophenyl)ethyl)-2-((3bS,4aR)-5,5-difluoro-3-(trifluoromethyl)-3b,4,4a,5-tetrahydro-1H-cyclopropa[3,4]cyclopenta[1,2-c]pyrazol-1-yl)acetamide
2375020-20-3
-
1H-Indazole-5-propanoic acid, α-[[[4-(1,2-dihydro-2-oxo-3-quinolinyl)-1-piperidinyl]carbonyl]amino]-7-methyl-, methyl ester, (αR)-
928014-64-6
-
Sacubitril Impurity
1015037-46-3
-
Bempedoic Acid Impurity 12
-
7-CHLORO-1-CYCLOPROPYL-6-FLUORO-4-OXO-1,4-DIHYDRO-QUINOLINE-3-CARBOXYLIC ACID ETHYL ESTER
86483-54-7
-
Thr(12)-Linear Liraglutide Impurity -
(S)-4-Methyl-N-((S)-1-(((R)-4-Methyl-1-((S)-2-Methyloxiran-2-yl)-1-oxopentan-2-yl)aMino)-1-oxo-3-phenylpropan-2-yl)-2-((S)-2-(2-MorpholinoacetaMido)-4-phenylbutanaMido)pentanaMide
2049025-67-2
-
Asn(12)-Linear Liraglutide Impurity
N,N-Dimethylformamide 68-12-2
Ricobendazole 54029-12-8
Direct Yellow 12 2870-32-8
Isonicotinic acid N-oxide 13602-12-5
2-Chloromethyl-4-methoxy-3-methylpyridine 124473-12-7
Solvent yellow 12 6370-43-0
Reactive Orange 12 (C.I 13248) 70161-14-7
Aluminum stearate 637-12-7
Reactive Red 35 12226-12-9
Leflunomide 75706-12-6